General Information
BounceWatch is an independent company data service, not affiliated with VG Life Sciences. To contact VG Life Sciences, visit vglifesciences.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does VG Life Sciences compare?
A PDF of VG Life Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting VG Life Sciences soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is VG Life Sciences on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About VG Life Sciences
Business keywords: pharmaceuticals, drug development, cancer treatment, autoimmune diseases, therapeutic research, patent technology, clinical trials, preclinical studies, FDA approval, metabolic disruption, peptide technology, innovative therapies, medical innovation
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $2.24M | 1 |
MedBridge Venture Fund
|
02 Oct 2013 |
| Post IPO Equity | $550.00K | - |
|
01 Mar 2013 |
VG Life Sciences Alternatives & Competitors
View All AlternativesPioneering the future of autoimmune and cancer treatment with innovative small peptides and molecule...
An emerging biotech discovering & developing novel therapies for cancer and viruses where other opti...
Dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases
FAQ About VG Life Sciences
Source: BounceWatch company record for VG Life Sciences, https://bouncewatch.com/company/vg-life-sciences, updated 26 December 2024. When citing, please name BounceWatch and link this page.